ArticleOncology letters2025
Real-world investigation for camrelizumab combined with apatinib in patients with advanced hepatocellular carcinoma.
Liyang Yin et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this paperpooled itcites it